315 related articles for article (PubMed ID: 23408630)
1. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.
Burns CC; Shaw J; Jorba J; Bukbuk D; Adu F; Gumede N; Pate MA; Abanida EA; Gasasira A; Iber J; Chen Q; Vincent A; Chenoweth P; Henderson E; Wannemuehler K; Naeem A; Umami RN; Nishimura Y; Shimizu H; Baba M; Adeniji A; Williams AJ; Kilpatrick DR; Oberste MS; Wassilak SG; Tomori O; Pallansch MA; Kew O
J Virol; 2013 May; 87(9):4907-22. PubMed ID: 23408630
[TBL] [Abstract][Full Text] [Related]
2. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
3. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, July 2019-February 2020.
Alleman MM; Jorba J; Greene SA; Diop OM; Iber J; Tallis G; Goel A; Wiesen E; Wassilak SGF; Burns CC
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(16):489-495. PubMed ID: 32324719
[TBL] [Abstract][Full Text] [Related]
4. Circulating vaccine-derived polioviruses in the Extreme North region of Cameroon.
Endegue-Zanga MC; Sadeuh-Mba SA; Iber J; Burns C; Nimpa-Mengouo M; Demanou M; Vernet G; Etoa FX; Njouom R
J Clin Virol; 2015 Jan; 62():80-3. PubMed ID: 25542478
[TBL] [Abstract][Full Text] [Related]
5. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
6. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022.
Bigouette JP; Henderson E; Traoré MA; Wassilak SGF; Jorba J; Mahoney F; Bolu O; Diop OM; Burns CC
MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(14):366-371. PubMed ID: 37022974
[TBL] [Abstract][Full Text] [Related]
7. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.
Wassilak S; Pate MA; Wannemuehler K; Jenks J; Burns C; Chenoweth P; Abanida EA; Adu F; Baba M; Gasasira A; Iber J; Mkanda P; Williams AJ; Shaw J; Pallansch M; Kew O
J Infect Dis; 2011 Apr; 203(7):898-909. PubMed ID: 21402542
[TBL] [Abstract][Full Text] [Related]
8. Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.
Yan D; Zhang Y; Zhu S; Chen N; Li X; Wang D; Ma X; Zhu H; Tong W; Xu W
Clin Vaccine Immunol; 2014 Jul; 21(7):1012-8. PubMed ID: 24850620
[TBL] [Abstract][Full Text] [Related]
9. Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 - Syria, 2017-2018.
Mbaeyi C; Wadood ZM; Moran T; ; Ather F; Stehling-Ariza T; Nikulin J; Al Safadi M; Iber J; Zomahoun L; Abourshaid N; Pang H; Collins N; Asghar H; Butt OUI; Burns CC; Ehrhardt D; Sharaf M
MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(24):690-694. PubMed ID: 29927908
[TBL] [Abstract][Full Text] [Related]
10. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2020-June 2021.
Alleman MM; Jorba J; Henderson E; Diop OM; Shaukat S; Traoré MA; Wiesen E; Wassilak SGF; Burns CC
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1691-1699. PubMed ID: 34882653
[TBL] [Abstract][Full Text] [Related]
11. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.
Diop OM; Burns CC; Sutter RW; Wassilak SG; Kew OM;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):640-6. PubMed ID: 26086635
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.
Alleman MM; Jorba J; Riziki Y; Henderson E; Mwehu A; Seakamela L; Howard W; Kadiobo Mbule A; Nsamba RN; Djawe K; Yapi MD; Mengouo MN; Gumede N; Ndoutabe M; Kfutwah AKW; Senouci K; Burns CC
Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A35-A47. PubMed ID: 36907733
[TBL] [Abstract][Full Text] [Related]
13. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
14. Responding to a cVDPV1 outbreak in Ukraine: Implications, challenges and opportunities.
Khetsuriani N; Perehinets I; Nitzan D; Popovic D; Moran T; Allahverdiyeva V; Huseynov S; Gavrilin E; Slobodianyk L; Izhyk O; Sukhodolska A; Hegazi S; Bulavinova K; Platov S; O'Connor P
Vaccine; 2017 Aug; 35(36):4769-4776. PubMed ID: 28528761
[TBL] [Abstract][Full Text] [Related]
15. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.
Yang CF; Naguib T; Yang SJ; Nasr E; Jorba J; Ahmed N; Campagnoli R; van der Avoort H; Shimizu H; Yoneyama T; Miyamura T; Pallansch M; Kew O
J Virol; 2003 Aug; 77(15):8366-77. PubMed ID: 12857906
[TBL] [Abstract][Full Text] [Related]
16. Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.
Jorba J; Diop OM; Iber J; Henderson E; Sutter RW; Wassilak SGF; Burns CC
MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1185-1191. PubMed ID: 29095803
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.
Saleem AF; Yousafzai MT; Mach O; Khan A; Quadri F; Weldon WC; Oberste MS; Zaidi SS; Alam MM; Sutter RW; Zaidi AKM
Vaccine; 2018 Mar; 36(13):1766-1771. PubMed ID: 29477307
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
J Virol; 2018 May; 92(9):. PubMed ID: 29444940
[TBL] [Abstract][Full Text] [Related]
19. Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria.
Sun Y; Keskinocak P; Steimle LN; Kovacs SD; Wassilak SG
Vaccine X; 2024 Jun; 18():100476. PubMed ID: 38617838
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
Kew O; Morris-Glasgow V; Landaverde M; Burns C; Shaw J; Garib Z; André J; Blackman E; Freeman CJ; Jorba J; Sutter R; Tambini G; Venczel L; Pedreira C; Laender F; Shimizu H; Yoneyama T; Miyamura T; van Der Avoort H; Oberste MS; Kilpatrick D; Cochi S; Pallansch M; de Quadros C
Science; 2002 Apr; 296(5566):356-9. PubMed ID: 11896235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
